Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Cepeda C, André VM, Hauptman JS, Yamazaki I, Huynh MN, Chang JW, Chen JY, Fisher RS, Vinters HV, Levine MS, Mathern GW.

Neurobiol Dis. 2012 Jan;45(1):310-21. doi: 10.1016/j.nbd.2011.08.015. Epub 2011 Aug 23.

2.

Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II.

Cepeda C, André VM, Yamazaki I, Hauptman JS, Chen JY, Vinters HV, Mathern GW, Levine MS.

Epilepsia. 2010 Jul;51 Suppl 3:160-5. doi: 10.1111/j.1528-1167.2010.02633.x.

3.

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.

Ann Neurol. 2012 Apr;71(4):539-51. doi: 10.1002/ana.22696. Epub 2012 Mar 23.

4.

Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits.

Cepeda C, André VM, Flores-Hernández J, Nguyen OK, Wu N, Klapstein GJ, Nguyen S, Koh S, Vinters HV, Levine MS, Mathern GW.

Dev Neurosci. 2005 Jan-Feb;27(1):59-76.

PMID:
15886485
5.

Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.

Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.

J Mol Neurosci. 2013 May;50(1):7-13. doi: 10.1007/s12031-012-9841-2. Epub 2012 Jul 3.

PMID:
22752548
6.

Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Shu HF, Yu SX, Zhang CQ, Liu SY, Wu KF, Zang ZL, Yang H, Zhou SW, Yin Q.

Brain Dev. 2013 Mar;35(3):252-60. doi: 10.1016/j.braindev.2012.04.007. Epub 2012 May 28.

PMID:
22647236
7.

Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia.

André VM, Wu N, Yamazaki I, Nguyen ST, Fisher RS, Vinters HV, Mathern GW, Levine MS, Cepeda C.

J Neuropathol Exp Neurol. 2007 Jun;66(6):491-504.

PMID:
17549009
8.

Pyramidal cell responses to gamma-aminobutyric acid differ in type I and type II cortical dysplasia.

André VM, Cepeda C, Vinters HV, Huynh M, Mathern GW, Levine MS.

J Neurosci Res. 2008 Nov 1;86(14):3151-62. doi: 10.1002/jnr.21752.

PMID:
18615638
9.

Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia.

Cepeda C, Hurst RS, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, André VM, Vinters HV, Ariano MA, Levine MS, Mathern GW.

J Neurosci Res. 2003 May 15;72(4):472-86.

PMID:
12704809
10.

Interneurons, GABAA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasia.

André VM, Cepeda C, Vinters HV, Huynh M, Mathern GW, Levine MS.

Epilepsia. 2010 Jul;51 Suppl 3:166-70. doi: 10.1111/j.1528-1167.2010.02634.x.

11.

Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?

Cepeda C, André VM, Vinters HV, Levine MS, Mathern GW.

Epilepsia. 2005;46 Suppl 5:82-8.

12.

Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.

Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.

J Neuroinflammation. 2016 Apr 19;13(1):85. doi: 10.1186/s12974-016-0546-2.

13.

Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.

Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.

Ann Neurol. 2008 Apr;63(4):454-65. doi: 10.1002/ana.21342.

14.

Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.

Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.

Folia Neuropathol. 2008;46(1):43-8.

15.

Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H.

J Neuropathol Exp Neurol. 2010 Aug;69(8):838-49. doi: 10.1097/NEN.0b013e3181eaeae5.

PMID:
20613633
16.

Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.

Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S.

Acta Neuropathol. 2002 Oct;104(4):418-24. Epub 2002 Jun 25.

PMID:
12200630
17.

Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.

Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.

Epilepsia. 2009 Dec;50(12):2629-37. doi: 10.1111/j.1528-1167.2009.02191.x. Epub 2009 Jul 2.

18.

Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.

Li S, Yu S, Zhang C, Shu H, Liu S, An N, Yang M, Yin Q, Yang H.

Brain Res. 2012 May 9;1453:46-55. doi: 10.1016/j.brainres.2012.03.009. Epub 2012 Mar 12.

PMID:
22459050
19.

Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia.

Cepeda C, André VM, Wu N, Yamazaki I, Uzgil B, Vinters HV, Levine MS, Mathern GW.

Epilepsia. 2007;48 Suppl 5:79-85. Erratum in: Epilepsia. 2007 Dec;48(12):2380.

20.

Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.

Wenzel HJ, Patel LS, Robbins CA, Emmi A, Yeung RS, Schwartzkroin PA.

Acta Neuropathol. 2004 Aug;108(2):97-108. Epub 2004 Jun 5.

PMID:
15185103

Supplemental Content

Support Center